Companies Sortera Bio

Biologics Discovery in the Age of AI

Spotlight

Sortera bio is a modality-agnostic platform technology that samples sequence space at unprecedented scale and efficiency. The company has developed a unique position to realise the vision of AI-guided drug discovery

The company's vision is to revolutionise the process of drug discovery through the integration of cutting-edge generative AI models and high-throughput experimental data collection to build the world's most extensive repository of biologics sequence-function data to build a leadership position in drug discovery

Cambridge Innovation Capital is a leading Series A investor in the Cambridge ecosystem.

We were born out of a unique relationship with the University of Cambridge and we maintain privileged access to its most inspiring ideas and people in life sciences and deep tech.

Discover more

Insights

Read More